The Amber Weitzer Podcast | Silhouettes of Success | Somer Baburek | Episode 109

Our V.I.P. Featured Guest Somer Baburek currently serves as the President & CEO of Hera Biotech, a women’s health company focused on commercializing a non-surgical diagnostic for early detection of endometriosis. Prior to founding Hera, Somer, spent seven years as the Director of Clinical Operations for Santalis Pharmaceuticals where she built out the clinical program at the company. During her tenure, Santalis expanded its clinical program from a single IND to four active INDs; and from 2 domestic clinical trials to over 10 clinical trials, including 2 international trials. In addition to her work at Santalis, Somer also worked for the Targeted Technology Fund (TTF), San Antonio’s largest life science venture capital fund, where she participated in due diligence on potential investments and served as a board representative, as needed. During her time with the TTF organization, Somer earned her MBA with a specialization in Data Analytics, from Louisiana State University. Prior to her work with the Targeted Technology Fund and Santalis, Somer attended the University of Texas San Antonio where she graduated Magna Cum Laude with a degree in entrepreneurship and was the winner of the prestigious C.I.T.E. (Center for Innovation Technology and Entrepreneurship) annual student competition, with a women’s health technology she invented.